← The SEC Ephemeris: the whole map
CMP Development LLC sildenafil
In the graph: all 4 documents (11 pages).
- Application
- NDA 214952
- Ticker
- CMP Development LLC
- Product
- sildenafil
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- April 28, 2022 · April 22, 2021 · February 23, 2021 · October 16, 2020
From FDA letters and SEC filings. Not investment or medical advice.